Topic
diabetes-treatments
1 stories related to this topic, newest first.
science5 days agoDeveloping
Eli Lilly Reports Strong Q1 2026 Earnings and Raises Full-Year Guidance
Eli Lilly reported first-quarter 2026 earnings and revenue that exceeded analyst estimates, driven by sales of its drugs Zepbound and Mounjaro. The company raised its full-year sales outlook by $2 billion and increased its adjusted profit guidance. Demand for these treatments con…